375 related articles for article (PubMed ID: 22053916)
1. Pleiotropic effects of pitavastatin.
Davignon J
Br J Clin Pharmacol; 2012 Apr; 73(4):518-35. PubMed ID: 22053916
[TBL] [Abstract][Full Text] [Related]
2. Pitavastatin: an overview.
Saito Y
Atheroscler Suppl; 2011 Nov; 12(3):271-6. PubMed ID: 22152281
[TBL] [Abstract][Full Text] [Related]
3. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive review on the lipid and pleiotropic effects of pitavastatin.
Sahebkar A; Kiaie N; Gorabi AM; Mannarino MR; Bianconi V; Jamialahmadi T; Pirro M; Banach M
Prog Lipid Res; 2021 Nov; 84():101127. PubMed ID: 34509516
[TBL] [Abstract][Full Text] [Related]
5. Are all statins the same? Focus on the efficacy and tolerability of pitavastatin.
da Silva PM
Am J Cardiovasc Drugs; 2011; 11(2):93-107. PubMed ID: 21446776
[TBL] [Abstract][Full Text] [Related]
6. Pitavastatin - from clinical trials to clinical practice.
Masana L
Atheroscler Suppl; 2010 Dec; 11(3):15-22. PubMed ID: 21193154
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacological and pharmacokinetic features and clinical effects of pitavastatin (Livalo Tablet)].
Yamazaki H; Fujino H; Kanazawa M; Tamaki T; Sato F; Suzuki M; Kitahara M
Nihon Yakurigaku Zasshi; 2004 May; 123(5):349-62. PubMed ID: 15118259
[TBL] [Abstract][Full Text] [Related]
8. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
Robinson JG
Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
[TBL] [Abstract][Full Text] [Related]
9. Pitavastatin: a new HMG-CoA reductase inhibitor for the treatment of hypercholesterolemia.
Ahmad H; Cheng-Lai A
Cardiol Rev; 2010; 18(5):264-7. PubMed ID: 20699675
[TBL] [Abstract][Full Text] [Related]
10. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
11. Pitavastatin calcium: clinical review of a new antihyperlipidemic medication.
Yee LL; Wright EA
Clin Ther; 2011 Aug; 33(8):1023-42. PubMed ID: 21816477
[TBL] [Abstract][Full Text] [Related]
12. Pitavastatin: a new HMG-CoA reductase inhibitor.
Wensel TM; Waldrop BA; Wensel B
Ann Pharmacother; 2010 Mar; 44(3):507-14. PubMed ID: 20179258
[TBL] [Abstract][Full Text] [Related]
13. Effect of pitavastatin on vascular reactivity in hypercholesterolemic rabbits.
Almeida EA; Ozaki MR
Arq Bras Cardiol; 2014 Jul; 103(1):4-12. PubMed ID: 25014056
[TBL] [Abstract][Full Text] [Related]
14. Pitavastatin: efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor.
Kajinami K; Takekoshi N; Saito Y
Cardiovasc Drug Rev; 2003; 21(3):199-215. PubMed ID: 12931254
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of pitavastatin for the treatment of hypercholesterolemia.
Chan P; Shao L; Tomlinson B; Zhang Y; Liu ZM
Expert Opin Pharmacother; 2019 Jan; 20(1):103-113. PubMed ID: 30482061
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?
Fabbri G; Maggioni AP
Adv Ther; 2009 May; 26(5):469-87. PubMed ID: 19444394
[TBL] [Abstract][Full Text] [Related]
17. Effects of pitavastatin on lipid profiles and high-sensitivity CRP in Japanese subjects with hypercholesterolemia: Kansai Investigation of Statin for Hyperlipidemic Intervention in Metabolism and Endocrinology (KISHIMEN) investigatars.
Koshiyama H; Taniguchi A; Tanaka K; Kagimoto S; Fujioka Y; Hirata K; Nakamura Y; Iwakura A; Hara K; Yamamoto T; Kuroe A; Ohya M; Fujimoto S; Hamamoto Y; Honjo S; Ikeda H; Nabe K; Tsuda K; Inagaki N; Seino Y; Kume N;
J Atheroscler Thromb; 2008 Dec; 15(6):345-50. PubMed ID: 19075492
[TBL] [Abstract][Full Text] [Related]
18. Place of pitavastatin in the statin armamentarium: promising evidence for a role in diabetes mellitus.
Kawai Y; Sato-Ishida R; Motoyama A; Kajinami K
Drug Des Devel Ther; 2011; 5():283-97. PubMed ID: 21625418
[TBL] [Abstract][Full Text] [Related]
19. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
Pedersen TR
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
[TBL] [Abstract][Full Text] [Related]
20. Pitavastatin: a review of its use in the management of hypercholesterolaemia or mixed dyslipidaemia.
Duggan ST
Drugs; 2012 Mar; 72(4):565-84. PubMed ID: 22356292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]